D.E. Shaw & Co’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,122
| Closed | -$106K | – | 3225 |
|
|
2024
Q3 | $106K | Buy |
+16,122
| New | +$106K | ﹤0.01% | 2882 |
|
|
2019
Q4 | – | Sell |
-20,322
| Closed | -$180K | – | 2744 |
|
|
2019
Q3 | $180K | Buy |
20,322
+11,890
| +141% | +$105K | ﹤0.01% | 2413 |
|
|
2019
Q2 | $121K | Sell |
8,432
-2,552
| -23% | -$36.6K | ﹤0.01% | 2472 |
|
|
2019
Q1 | $361K | Sell |
10,984
-1,436
| -12% | -$47.2K | ﹤0.01% | 2205 |
|
|
2018
Q4 | $738K | Sell |
12,420
-9,488
| -43% | -$564K | ﹤0.01% | 1962 |
|
|
2018
Q3 | $3.07M | Sell |
21,908
-7,105
| -24% | -$997K | ﹤0.01% | 1347 |
|
|
2018
Q2 | $3.56M | Sell |
29,013
-3,779
| -12% | -$464K | ﹤0.01% | 1308 |
|
|
2018
Q1 | $2.93M | Sell |
32,792
-3,251
| -9% | -$291K | ﹤0.01% | 1314 |
|
|
2017
Q4 | $2M | Sell |
36,043
-3,343
| -8% | -$185K | ﹤0.01% | 1529 |
|
|
2017
Q3 | $1.66M | Buy |
39,386
+2,407
| +7% | +$102K | ﹤0.01% | 1557 |
|
|
2017
Q2 | $1.56M | Sell |
36,979
-5,328
| -13% | -$224K | ﹤0.01% | 1542 |
|
|
2017
Q1 | $2.37M | Buy |
42,307
+4,604
| +12% | +$257K | ﹤0.01% | 1298 |
|
|
2016
Q4 | $1.44M | Buy |
37,703
+6,513
| +21% | +$249K | ﹤0.01% | 1601 |
|
|
2016
Q3 | $1.24M | Sell |
31,190
-3,835
| -11% | -$152K | ﹤0.01% | 1620 |
|
|
2016
Q2 | $2.52M | Buy |
35,025
+7,069
| +25% | +$508K | ﹤0.01% | 1319 |
|
|
2016
Q1 | $2.24M | Buy |
+27,956
| New | +$2.24M | ﹤0.01% | 1336 |
|
|
2015
Q3 | – | Sell |
-731
| Closed | -$304K | – | 2626 |
|
|
2015
Q2 | $304K | Buy |
+731
| New | +$304K | ﹤0.01% | 2335 |
|